Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cetta

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Archives of Dermatology|April 1, 1987
Prolidase deficiency in two siblings with chronic leg ulcerations. Clinical, biochemical, and morphologic aspectsA Leoni, G Cetta, R Tenni, et al.
American Journal of Respiratory Cell and Molecular Biology|November 6, 2001
Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibioticsM Gorrini, A Lupi, S Viglio, et al.
Connective Tissue Research|January 1, 1993
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfectaG Cetta, A Rossi, R Tenni, et al.
The Biochemical Journal|April 15, 1982
Biochemical and morphological modifications in rabbit Achilles tendon during maturation and ageingG Cetta, R Tenni, G Zanaboni, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 20, 1998
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate productionA Rossi, I Kaitila, W R Wilcox, et al.
European Journal of Biochemistry|February 1, 1993
Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chainM Valli, A Sangalli, A Rossi, et al.
The Journal of Pharmacy and Pharmacology|May 15, 2004
Biodegradable microspheres for prolidase delivery to human cultured fibroblastsA Lupi, P Perugini, I Genta, et al.
American Journal of Human Genetics|April 1, 1990
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndromeM Godfrey, S Olson, R G Burgio, et al.
Biochemical and Molecular Medicine|February 12, 1998
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutationA Forlino, E D'amato, M Valli, et al.
Human Genetics|July 1, 1992
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen geneM Mottes, A Sangalli, M Valli, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Archives of Dermatology|April 1, 1987
Prolidase deficiency in two siblings with chronic leg ulcerations. Clinical, biochemical, and morphologic aspectsA Leoni, G Cetta, R Tenni, et al.
American Journal of Respiratory Cell and Molecular Biology|November 6, 2001
Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibioticsM Gorrini, A Lupi, S Viglio, et al.
Connective Tissue Research|January 1, 1993
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfectaG Cetta, A Rossi, R Tenni, et al.
The Biochemical Journal|April 15, 1982
Biochemical and morphological modifications in rabbit Achilles tendon during maturation and ageingG Cetta, R Tenni, G Zanaboni, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 20, 1998
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate productionA Rossi, I Kaitila, W R Wilcox, et al.
European Journal of Biochemistry|February 1, 1993
Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chainM Valli, A Sangalli, A Rossi, et al.
The Journal of Pharmacy and Pharmacology|May 15, 2004
Biodegradable microspheres for prolidase delivery to human cultured fibroblastsA Lupi, P Perugini, I Genta, et al.
American Journal of Human Genetics|April 1, 1990
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndromeM Godfrey, S Olson, R G Burgio, et al.
Biochemical and Molecular Medicine|February 12, 1998
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutationA Forlino, E D'amato, M Valli, et al.
Human Genetics|July 1, 1992
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen geneM Mottes, A Sangalli, M Valli, et al.
Pageof 8